As established in previous studies, NF-κB serves as a central mediator linking hepatic inflammation, fibrosis, and tumorigenesis, representing a critical therapeutic target in liver fibrosis and HCC prevention [64]. Here, NFKB1 is linked to Hepatic fibrosis.